>
Switch to:

iCo Therapeutics Interest Expense

: $0.00 Mil (TTM As of Sep. 2020)
View and export this data going back to 2009. Start your Free Trial

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. iCo Therapeutics's interest expense for the three months ended in Sep. 2020 was $ 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2020 was $0.00 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. iCo Therapeutics's Operating Income for the three months ended in Sep. 2020 was $ -0.15 Mil. iCo Therapeutics's Interest Expense for the three months ended in Sep. 2020 was $ 0.00 Mil. iCo Therapeutics has no debt. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

iCo Therapeutics Interest Expense Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

iCo Therapeutics Annual Data
Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Interest Expense Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

iCo Therapeutics Quarterly Data
Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
Interest Expense Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

iCo Therapeutics Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2020 was 0 (Dec. 2019 ) + 0 (Mar. 2020 ) + 0 (Jun. 2020 ) + 0 (Sep. 2020 ) = $0.00 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

iCo Therapeutics  (OTCPK:ICOTF) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

iCo Therapeutics's Interest Expense for the three months ended in Sep. 2020 was $0.00 Mil. Its Operating Income for the three months ended in Sep. 2020 was $-0.15 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2020 was $0.00 Mil.

iCo Therapeutics's Interest Coverage for the quarter that ended in Sep. 2020 is calculated as

iCo Therapeutics had no debt.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

iCo Therapeutics Inc has no debt.

iCo Therapeutics Interest Expense Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)